Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype

作者: Eleni Mylona , Konstantinos Tzelepis , Irene Theohari , Ioanna Giannopoulou , Christos Papadimitriou

DOI: 10.1111/HIS.12013

关键词:

摘要: Aims: To study the clinicopathological and prognostic value of cyclin D1 overexpression in patients with breast carcinoma. Methods results: Immunohistochemistry was performed on paraffin-embedded tissue specimens from 290 invasive carcinomas to detect proteins D1, oestrogen receptor (ER), progesterone (PR), p53, c-erbB2, topoisomerase IIa (topoIIa). Cyclin staining quantified using a computerized image analysis method. characterized smaller, ER-positive PR-positive tumours (P = 0.017, P < 0.0001, respectively), lower histological nuclear grade 0.011 reduced expression topoIIa 0.001) p53 0.001). found have an independent favourable impact overall survival both unselected cohort 0.011) ER-negative lymph node-positive 0.034 0.015, respectively). In triple-negative tumours, impacts relapse-free 0.002 for both). Conclusions: This is first immunohistochemical dissociate advantageous effect its association ER expression, provide evidence that may be marker prolonged patient subgroups aggressive phenotypes.

参考文章(39)
Annalisa Roberti, Marcella Macaluso, Antonio Giordano, Alterations in Cell Cycle Regulatory Genes in Breast Cancer Breast Cancer in the Post-Genomic Era. pp. 55- 77 ,(2009) , 10.1007/978-1-60327-945-1_4
Peter Devilee, Fattaneh A. Tavassoli, Pathology and Genetics of Tumours of the Breast and Female Genital Organs World Hhealth Organization Classification of Tumours. ,(2003)
Robert L Sutherland, Elizabeth A Musgrove, Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models Breast Cancer Research. ,vol. 4, pp. 14- 17 ,(2001) , 10.1186/BCR411
Ho Man Chan, Marija Krstic-Demonacos, Linda Smith, Constantinos Demonacos, Nicholas B. La Thangue, Acetylation control of the retinoblastoma tumour-suppressor protein. Nature Cell Biology. ,vol. 3, pp. 667- 674 ,(2001) , 10.1038/35083062
P J van Diest, L Jannink, C J Meijer, P van der Valk, J S de Jong, J P Baak, R J Michalides, H L Peterse, Cyclin D1 expression in invasive breast cancer: correlations and prognostic value American Journal of Pathology. ,vol. 150, pp. 705- 711 ,(1997)
LYDIA L. NAKOPOULOU, ANASTASIA ALEXIADOU, GEORGE E. THEODOROPOULOS, ANDREAS CH. LAZARIS, ANASTASIA TZONOU, ANDONIS KERAMOPOULOS, Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer. The Journal of Pathology. ,vol. 179, pp. 31- 38 ,(1996) , 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O
M. Sabbah, D. Courilleau, J. Mester, G. Redeuilh, Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 11217- 11222 ,(1999) , 10.1073/PNAS.96.20.11217
Cheryl Gillett, Paul Smith, Walter Gregory, Michael Richards, Rosemary Millis, Gordon Peters, Diana Barnes, Cyclin D1 and prognosis in human breast cancer International Journal of Cancer. ,vol. 69, pp. 92- 99 ,(1996) , 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.0.CO;2-Q
Jorge S Reis-Filho, Kay Savage, Maryou B K Lambros, Michelle James, Dawn Steele, Robin L Jones, Mitch Dowsett, Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis. Modern Pathology. ,vol. 19, pp. 999- 1009 ,(2006) , 10.1038/MODPATHOL.3800621
R Michalides, P Hageman, H van Tinteren, L Houben, E Wientjens, R Klompmaker, J Peterse, A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. British Journal of Cancer. ,vol. 73, pp. 728- 734 ,(1996) , 10.1038/BJC.1996.128